DNase I levels and disease outcome in JIA patients treated with etanercept

Podobne zapisy

• DNase I levels and disease outcome in JIA patients treated with etanercept
  od: Damjanov N, i wsp.
  Wydane: (2011-09-01)
• DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
  od: Vojinovic, J, i wsp.
  Wydane: (2008)
• Inflence of clinical and genetic characteristics on ability to achive and maintain remission in JIA patients on etanercept treatment
  od: Lazarevic, Dragana S, i wsp.
  Wydane: (2014)
• Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
  od: Vojinovic, J, i wsp.
  Wydane: (2011)
• Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
  od: Susic, G, i wsp.
  Wydane: (2008)